Katharina Tscherny, Juergen Grafeneder, Bettina Wandl, Maximilian Niederer, Martina Haider, Eva Katharina Masel, Dominik Roth, Alexander Egger
{"title":"Symptom tracking made simple? Observational data on the clinical use of the PERS<sup>2</sup>ON score in cancer patients receiving palliative care.","authors":"Katharina Tscherny, Juergen Grafeneder, Bettina Wandl, Maximilian Niederer, Martina Haider, Eva Katharina Masel, Dominik Roth, Alexander Egger","doi":"10.1007/s00508-025-02553-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>A standardized assessment of symptoms is essential for individualized palliative care (PC). While numerous tools exist, many are too complex for daily clinical use.</p><p><strong>Objective: </strong>The PERS<sup>2</sup>ON score was developed as a brief and practical tool to assess symptom burden in PC. This study aimed to evaluate its feasibility in a rural hospital setting, although it did not include formal feasibility metrics such as recruitment or adherence rates.</p><p><strong>Methods: </strong>Patients admitted to the palliative care unit of a rural hospital were assessed using the PERS<sup>2</sup>ON score, which includes seven items: pain, eating, rehabilitation, social situation, suffering, oxygen/dyspnea, and nausea/emesis. Each item is scored from 0 to 10, with higher scores indicating greater burden. Assessments were conducted on admission, after 7 days, and at discharge. Symptom scores were analyzed for change over time.</p><p><strong>Results: </strong>Of 60 admitted patients, 40 met the inclusion criteria. Reassessment was possible in 35 patients after 7 days and in 31 patients at discharge. The mean PERS<sup>2</sup>ON score decreased from 28 (SD 12) on admission to 21 (SD 11) after 7 days (difference: 7, 95% confidence interval, CI: 3-11, p = 0.002), and to 17 (SD 10) at discharge (difference: 11, 95% CI: 6-15, p < 0.001).</p><p><strong>Conclusion: </strong>The PERS<sup>2</sup>ON score was feasible to implement and enabled consistent symptom monitoring. Its use may support structured clinical assessment and targeted symptom management even in smaller or rural palliative care units.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"335-341"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener Klinische Wochenschrift","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00508-025-02553-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Context: A standardized assessment of symptoms is essential for individualized palliative care (PC). While numerous tools exist, many are too complex for daily clinical use.
Objective: The PERS2ON score was developed as a brief and practical tool to assess symptom burden in PC. This study aimed to evaluate its feasibility in a rural hospital setting, although it did not include formal feasibility metrics such as recruitment or adherence rates.
Methods: Patients admitted to the palliative care unit of a rural hospital were assessed using the PERS2ON score, which includes seven items: pain, eating, rehabilitation, social situation, suffering, oxygen/dyspnea, and nausea/emesis. Each item is scored from 0 to 10, with higher scores indicating greater burden. Assessments were conducted on admission, after 7 days, and at discharge. Symptom scores were analyzed for change over time.
Results: Of 60 admitted patients, 40 met the inclusion criteria. Reassessment was possible in 35 patients after 7 days and in 31 patients at discharge. The mean PERS2ON score decreased from 28 (SD 12) on admission to 21 (SD 11) after 7 days (difference: 7, 95% confidence interval, CI: 3-11, p = 0.002), and to 17 (SD 10) at discharge (difference: 11, 95% CI: 6-15, p < 0.001).
Conclusion: The PERS2ON score was feasible to implement and enabled consistent symptom monitoring. Its use may support structured clinical assessment and targeted symptom management even in smaller or rural palliative care units.
期刊介绍：
The Wiener klinische Wochenschrift - The Central European Journal of Medicine - is an international scientific medical journal covering the entire spectrum of clinical medicine and related areas such as ethics in medicine, public health and the history of medicine. In addition to original articles, the Journal features editorials and leading articles on newly emerging topics, review articles, case reports and a broad range of special articles. Experimental material will be considered for publication if it is directly relevant to clinical medicine. The number of international contributions has been steadily increasing. Consequently, the international reputation of the journal has grown in the past several years. Founded in 1888, the Wiener klinische Wochenschrift - The Central European Journal of Medicine - is certainly one of the most prestigious medical journals in the world and takes pride in having been the first publisher of landmarks in medicine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
